Structured evidence table for Maca Menopause Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Maca Menopause Randomized Trial | Background: Middle-aged women frequently experience diverse physical and psychological symptoms, including depression, anxiety, sleep disturbances, vasomotor symptoms, and reduced quality of life, during menopause. | 1 | Kim JH (2025) | Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. |
| Maca Menopause Randomized Trial | Risk of bias was assessed using the Cochrane risk of bias tool, and meta-analyses were performed using a random effects model. | 1 | Kim JH (2025) | Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. |
| Maca Menopause Randomized Trial | Results: Nonpharmacological interventions significantly reduced symptoms of depression (standardized mean difference (SMD) = -1.10), anxiety (-0.82), sleep disturbances (-0.90), menopausal symptoms (-1.18), and hot flashes (-0.34). | 1 | Kim JH (2025) | Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. |
| Maca Menopause Randomized Trial | With increasing concerns regarding the side effects of hormone therapy, nonpharmacological interventions have emerged as safer alternatives for symptom management. | 1 | Kim JH (2025) | Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. |
| Maca Menopause Randomized Trial | Data synthesis was performed with RevMan 5.4, and the certainty of the evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. | 1 | de Aquino ACQ (2025) | Pharmacological treatment of antidepressant-induced sexual dysfunction in women: A systematic review and meta-analysis of randomized clinical trials. |
| Maca Menopause Randomized Trial | is the most effective pharmacological treatment for AISD in women, though the evidence quality is low. | 1 | de Aquino ACQ (2025) | Pharmacological treatment of antidepressant-induced sexual dysfunction in women: A systematic review and meta-analysis of randomized clinical trials. |
| Maca Menopause Randomized Trial | Background Antidepressant-Induced Sexual Dysfunction (AISD) is a significant public health concern, and pharmacological treatments may offer potential solutions for managing this side effect. | 1 | de Aquino ACQ (2025) | Pharmacological treatment of antidepressant-induced sexual dysfunction in women: A systematic review and meta-analysis of randomized clinical trials. |
| Maca Menopause Randomized Trial | This study aims to assess the efficacy of these therapies in treating AISD in women, as well as their impact on improving depressive symptoms. | 1 | de Aquino ACQ (2025) | Pharmacological treatment of antidepressant-induced sexual dysfunction in women: A systematic review and meta-analysis of randomized clinical trials. |
Source documents